Company Data
Prelude Therapeutics Incorporated
Ticker
PRLD
Current Price
$0.83 -6.44%
Market Cap
$46.9M
Price Target
Refer to Report
Volume
94.6K
52wk Range
$0.6101 - $6.8
Overview
Prelude Therapeutics Incorp is a clinical-stage precision oncology company focused on discovering and developing small molecule therapies optimized to target the key driver mechanisms in cancers with high unmet need.